Cosmos Health Stock Market Value
| COSM Stock | USD 0.37 0.01 2.63% |
| Symbol | Cosmos |
Will Health Care Providers & Services sector continue expanding? Could Cosmos diversify its offerings? Factors like these will boost the valuation of Cosmos Health. Projected growth potential of Cosmos fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cosmos Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.77) | Revenue Per Share | Quarterly Revenue Growth 0.379 | Return On Assets | Return On Equity |
Investors evaluate Cosmos Health using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Cosmos Health's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Cosmos Health's market price to deviate significantly from intrinsic value.
It's important to distinguish between Cosmos Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cosmos Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Cosmos Health's market price signifies the transaction level at which participants voluntarily complete trades.
Cosmos Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cosmos Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cosmos Health.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in Cosmos Health on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding Cosmos Health or generate 0.0% return on investment in Cosmos Health over 90 days. Cosmos Health is related to or competes with Femasys, Scynexis, Lisata Therapeutics, Nexgel, MetaVia, Passage Bio, and CASI Pharmaceuticals. Cosmos Holdings Inc. operates as a vertically integrated pharmaceutical company More
Cosmos Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cosmos Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cosmos Health upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 29.76 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 8.16 |
Cosmos Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cosmos Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cosmos Health's standard deviation. In reality, there are many statistical measures that can use Cosmos Health historical prices to predict the future Cosmos Health's volatility.| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.96) | |||
| Total Risk Alpha | (1.19) | |||
| Treynor Ratio | (0.55) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cosmos Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cosmos Health February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | (0.54) | |||
| Mean Deviation | 3.81 | |||
| Coefficient Of Variation | (627.87) | |||
| Standard Deviation | 5.52 | |||
| Variance | 30.45 | |||
| Information Ratio | (0.17) | |||
| Jensen Alpha | (0.96) | |||
| Total Risk Alpha | (1.19) | |||
| Treynor Ratio | (0.55) | |||
| Maximum Drawdown | 29.76 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 8.16 | |||
| Skewness | 1.33 | |||
| Kurtosis | 4.51 |
Cosmos Health Backtested Returns
Cosmos Health secures Sharpe Ratio (or Efficiency) of -0.12, which signifies that the company had a -0.12 % return per unit of risk over the last 3 months. Cosmos Health exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cosmos Health's Mean Deviation of 3.81, standard deviation of 5.52, and Risk Adjusted Performance of (0.12) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.63, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cosmos Health will likely underperform. At this point, Cosmos Health has a negative expected return of -0.71%. Please make sure to confirm Cosmos Health's total risk alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Cosmos Health performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.24 |
Weak predictability
Cosmos Health has weak predictability. Overlapping area represents the amount of predictability between Cosmos Health time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cosmos Health price movement. The serial correlation of 0.24 indicates that over 24.0% of current Cosmos Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.24 | |
| Spearman Rank Test | 0.4 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Cosmos Health Correlation, Cosmos Health Volatility and Cosmos Health Performance module to complement your research on Cosmos Health. To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Cosmos Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.